baber/WOPTO huggingface dataset:
Patent DK-2255685-T3 (DK)
Inventor: COLLIER JOHN
IPC: A41D1/06
Filed: 2008-02-04
Granted: 2013-10-28
Abstract: One embodiment of the present invention provides a vented apparel, comprising: an outer shell (103); an inner liner (105) disposed adjacent at least a portion of an inside of the outer shell (103); a vent (107) through the outer shell, wherein the vent is substantially covered by a screen (109); a zipper (111) on the inner liner (105); and an adjusting mechanism (113) on the outer shell; wherein the adjusting mechanism (113) is connected to the zipper (111) in order to move the zipper between a closed position and an open position. Another embodiment of the present invention provides a vent system, comprising: a vent (207) through an outer shell (203) of an item incorporating the vent system, wherein the vent is substantially covered by a screen (209); a zipper on an inner liner of the item, wherein the inner liner is disposed adjacent at least a portion of an inside of the outer shell; and an adjusting mechanism (213) on the outer shell (203); wherein the adjusting mechanism is connected to the zipper in order to move the zipper between a closed position and an open position.
Patent DK-2327763-T3 (DK)
Inventor: SCHENDEL DOLORES
IPC: C12N15/12
Filed: 2006-08-04
Granted: 2018-05-22
Abstract: The present invention is directed to a method of generating antigen specific T cells. Furthermore, the invention is directed to antigen specific T cells, isolated transgenic TCR's, pharmaceutical compositions containing same and their use in adoptive cell therapy. This invention in particular pertains to the use of cells co-expressing allogeneic MHC molecules and antigens to induce peptide-specific T cells from non-selected allogeneic T cell repertoires.
Patent DK-2766003-T3 (DK)
Inventor: PICKERING GISÈLE
IPC: A61P25/02
Filed: 2012-10-10
Granted: 2018-03-19
Abstract: The invention relates to an analgesic composition containing memantine. According to the invention, such a composition is administered daily to a human patient having to undergo a surgical operation, over a period ranging from one day to a plurality of days before said surgical operation, in order to prevent and treat the development of post-operative neuropathic pain in this same patient.
Patent DK-3046901-T3 (DK)
Inventor: DUGGAN KAREN ANNETTE
IPC: C07C235/34
Filed: 2014-09-17
Granted: 2018-01-02
Abstract: The present invention relates to a novel terphenyl compound and its use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
Patent DK-0386745-T3 (DK)
Inventor: KUBBUTAT ALBERT
IPC: C04B26/14
Filed: 1990-03-07
Granted: 1993-08-02
Abstract: A process is useful for manufacturing wall boards from balls of expanded glass, expanded clay, pumice granules, mica or a similar material and a foamed organic binder such as epoxide resin, PU phenol resin or the like. The binder is mixed with the balls, foamed and hardened between two die plates arranged at a distance apart to form a matrix. To obtain an extremely light but nevertheless stable wall board, a plurality of uniformly distributed recesses opening onto the outside of the board are formed in the mixture located between the two die plates while it is being compacted and before it hardens. The device used to implement the process comprises two die plates (1, 2) which can be moved towards each other in a press to compress the mixture introduced. The surface of both die plates (1, 2) is covered with a plurality of uniformly distributed, conical moulded bodies (4, 5) whose cross-section parallel to the surface of the die plate decreases in the direction of the other die plate.
Patent DK-0411268-T3 (DK)
Inventor: KNORR ANDREAS
IPC: C12P17/16
Filed: 1990-05-31
Granted: 1995-08-14
Abstract: The present invention relates to 7H-dibenzo[1,5]-dioxocin-5-ones of the general formula (I) 
<IMAGE>
 in which R<1> - R<8>, R<14> and R<15> have the meaning given in the description, to their use in medicaments, and processes for their preparation, in particular their use in medicaments having a circulatory activity.
Patent DK-0470959-T3 (DK)
Inventor: SMEDS STAFFAN
IPC: B01F3/12
Filed: 1990-01-11
Granted: 1995-12-18
Abstract: PCT No. PCT/SE90/00018 Sec. 371 Date Oct. 30, 1991 Sec. 102(e) Date Oct. 30, 1991 PCT Filed Jan. 11, 1990 PCT Pub. No. WO90/13264 PCT Pub. Date Nov. 15, 1990.The present invention relates to an arrangement for the manufacture of bone cement by mixing together its constituent components comprising a mixing cylinder (1) in the form of a tube with a bottom (2) and a lid (3) and inside the mixing cylinder an axially movable agitator (4). The agitator consists of a piston-like agitator disc (4a), which is perforated by channels (4a1), through which the components of the bone cement are caused to flow during the mixing procedure and an agitator rod (4b) resembling a piston rod operatively connected to the agitator disc (4a) and supported in the lid (3) in such a way that it is free to slide. The invention is characterized in that the agitator rod (4b) has an axial channel (4b1), which is closed off at the agitator disc (4a) in such a way that it is capable of being opened. The bottom (2) is so arranged, under the effect of an axial force, as to be displaced like a piston axially in the direction of the lid (3), in conjunction with which the bone cement flows out through the channel (4b1) after it has been opened.
Patent DK-0443598-T3 (DK)
Inventor: STUEBER WERNER DR
IPC: C07K7/00
Filed: 1991-02-22
Granted: 1995-09-25
Abstract: Peptides of the formula I  A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15  in which   A1 is hydrogen, cysteine, acetylcysteine, one or two alkyl groups with 1-4 C atoms, an acyl group with 2-10 C atoms, an acyl group with 2-10 C atoms and another carboxyl group, or a protective group customary in peptide chemistry,   A2 is a bond, Asn, Asp, Gln or Glu,   A3 is a bond, Gly or Ala,   A4 is Glu or Asp,   A5 is Phe, Tyr, Trp, Pgl (phenylglycine) or Nal (naphthylalanine),   A6 is Glu or Asp,   A7 is Glu, Asp, Pro or Ala,   A8 is Ile, Leu, Val, Nle or Phe,   A9 is Pro or Hyp,   A10 is Glu or Asp,   A11 is Glu or Asp, A12 is Phe(SO3H) or Phe(PO3H2) (preferably in the p position) or Pgl(SO3H) or Pgl(PO3H2) (preferably in the p position),   A13 is a bond, Leu, Ile, Val or Ala,   A14 is a bond, Gln, Asn, Glu, Asp or Cys and A15 is Cys, Cys-amide, an OH group of the alpha-carboxyl group, free or esterified with a lower alcohol with up to 4 C atoms, which can also be in the form of the carboxamide functionality whose hydrogens can optionally be replaced by alkyl groups with up to 4 C atoms, and a process for the preparation thereof are described. These peptides inhibit blood coagulation and can be used as anticoagulants.
Patent DK-0482425-T3 (DK)
Inventor: SCHAECHTERLE WERNER
IPC: G01R1/22
Filed: 1991-10-09
Granted: 1996-01-15
Abstract: In a device for measuring current, preferably current and voltage, on conductors of a single or multiphase system, especially conductors of low-voltage power supply installations, having an air-cored coil (123), which is located on a part of its length in a device housing (101), as a current sensor, the air-cored coil (123) has a first section (123a), which projects from the device housing (101), has a non-changing shape, similar to a hook that is open towards the device housing (1; 101), and has a second section (123d), which likewise has a non-changing shape and is guided such that it can move in a guide of the device housing (101) between a position in which its free end is connected to that of the first section (123a) and in which it complements the first section (123a) to form a U-like bracket having limbs which are connected to the device housing (101), and a position in which the hook formed by the first section (123a) is open. A section (123c) which is free of ferromagnetic material, is connected on the one hand to the first section (123a) of the air-cored coil (123) and on the other hand to the second section (123d) of the latter, is provided inside the device housing (101). <IMAGE>
Patent DK-0443747-T3 (DK)
Inventor: PADERA ROBERT F
IPC: C02F1/42
Filed: 1991-02-06
Granted: 1994-02-28
Abstract: A flow collector/distributor for a water treatment tank comprises a housing proportioned to communicate through a wall of the water treatment tank to provide flow communication between the tank interior and the tank exterior. The collector/distributor defines an inner end to project inwardly from the tank wall and an outward end to face outwardly from the tank wall. A plurality of slots are defined in the tubular housing, positioned to communicate with the tank interior when the collector/distributor is seated in the tank wall. The slots are of a width which is narrow enough to permit water flow therethrough while substantially preventing passage therethrough of water treatment material present within the tank. One or more one-way valves are provided to permit water flow through all of the slots from the tank interior through the collector/distributor to the tank exterior, but to prevent water flow through some, but not all, of the slots from the tank exterior through the collector/distributor to the tank interior. Also, a novel slot design is disclosed having improved flow characteristics. <IMAGE>
Patent DK-0539378-T3 (DK)
Inventor: STEINDORF RICHARD E
IPC: C11D1/68
Filed: 1991-04-15
Granted: 1994-09-12
Abstract: A concentrated, extremely active, solid, food grade rinse aid which includes a sorbitan fatty acid ester, a sucrose fatty acid ester, a polyglycerol fatty acid ester, a water soluble filler, and optionally a processing aid.
Patent DK-0546636-T3 (DK)
Inventor: VAN DEN BERG RUTH
IPC: B62D13/02
Filed: 1992-12-08
Granted: 1997-05-20
Abstract: The present invention provides a pulled vehicle (1) comprising:     a rear axle (2) steering the rear wheels (4);   a rotary element (9) on the front side of the vehicle; a coupling between the rotary element and the steerable wheels in order to place the steerable wheels into a desired position relative to the rotary element; and means (30) for indicating the desired position of the steerable wheels in a predetermined position of the rotary element. In the case of a semi-trailer the position of the rotary element is directly determined by the position of the tractor relative to the pulled vehicle; in the case of a trailer this position is determined by the front wheels and therefore often indirectly by the tractor. Finally, a rotary element is also known wherein a so-called jeep dolly often with non-steered wheels is received between semi-trailer and tractor; in such a combination the position of the rotary element is determined by the tractor via the jeep dolly.   <IMAGE>
Patent DK-0562054-T3 (DK)
Inventor: KATTI KATTESH V
IPC: C07F13/00
Filed: 1992-05-01
Granted: 1999-12-20
Abstract: A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises either a phosphorous or germanium core and at least two hydrazine groups forming a ligand for bonding to a metal extending from the phosphorous or germanium core.
Patent DK-0587087-T3 (DK)
Inventor: HEMMERLE HORST DR
IPC: A61K31/415
Filed: 1993-09-06
Granted: 1999-12-06
Abstract: Esters of cyclohexane derivatives of the formula I <IMAGE>  in which A-B, R<3>, R<4>, R<5>, Y and Z have the stated meanings, for use as inhibitors of the glucose-6-phosphatase system in the liver of mammals are described. The compounds are suitable for producing pharmaceutical products.
Patent DK-0618906-T3 (DK)
Inventor: KARJALAINEN ARTO JOHANNES
IPC: A61P25/28
Filed: 1992-12-18
Granted: 1999-01-25
Abstract: PCT No. PCT/FI92/00349 Sec. 371 Date Sep. 19, 1994 Sec. 102(e) Date Sep. 19, 1994 PCT Filed Dec. 18, 1992 PCT Pub. No. WO93/13074 PCT Pub. Date Jul. 8, 1993.The invention provides compounds of the formula    <IMAGE>  I  wherein Y is -CH2- or -CO-; R1 is F, Cl or OH; R2 is H, F or Cl; and R3 is H, CH3 or CH2CH3, excluding 4-(5-chloro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole and 4-(4-chloro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole; and their non-toxic acid addition salts and mixtures thereof. Processes for the preparation of these compounds are described, as are pharmaceutical compositions comprising at least one of the compounds or its salt. The compounds and their non-toxic salts exhibit valuable pharmacological activity and are highly selective and long acting antagonists at  alpha 2-adrenoceptors. Their peroral bioavailability is good. The compounds are especially useful in the treatment of cognitive disorders.
Patent DK-0623134-T3 (DK)
Inventor: SESSLER JONATHAN L
IPC: A61P35/00
Filed: 1993-01-07
Granted: 2003-03-17
Abstract: The present invention relates to the use of water-soluble texaphyrin-diamagnetic metal complexes retaining lipophilicity as photosensitizers in the treatment of benign and malignant neoplastic tissue.
Patent DK-0654201-T3 (DK)
Inventor: SCHMIDT WERNER DR ING
IPC: H04B7/26
Filed: 1993-05-29
Granted: 1996-12-23
Abstract: The description relates to a process for improving radio reception on a road system consisting of individual traffic lanes intersecting at any  angle via a cellular mobile radio system which comprises a number of adjacent and mutually contacting or partially overlapping radio cells. In the boundary region of each cell there is at least one fixed transmitter with at least one sector aerial which covers at least part of a region of this cell to be supplied with radio frequencies of a channel group. At least one further fixed transmitter is arranged in the transition region with an immediately adjacent cell and at this post there is at least one sector aerial providing the cell to be supplied itself with the same channel group as the fixed transmitter, two or more fixed transmitters transmit simultaneously to a cell and the cells in a linear road structure have a star structure consisting of mutually overlapping ellipsoidal partial areas.
Patent DK-0656118-T3 (DK)
Inventor: CATT MICHAEL
IPC: G01N33/68
Filed: 1993-08-10
Granted: 1997-08-18
Abstract: A method of monitoring the status of a current ovulation cycle of an individual human female subject, involving repeated testing of the body fluid concentration of at least one analyte of significance in relation to the status of the ovulation cycle, such as urinary E3G, during at least the pre-ovulation phase of the current ovulation cycle of the individual subject, wherein testing for said analyte concentration during the current ovulation cycle is commenced a plurality of days (preferably at least 5) following the onset of menses but at least 2 numerical days in advance of the earliest numerical day on which actual ovulation has occurred in one or more previous ovulation cycles in the same individual subject.
Patent DK-0654770-T3 (DK)
Inventor: WERNER JUERG DR
IPC: G08B17/00
Filed: 1994-09-05
Granted: 2000-07-17
Abstract: The arrangement contains a plurality of detectors which are connected to a central station and of which some are fitted with at least two sensors (1, 2) for monitoring different fire characteristics. One sensor (1) is preferably a thermal sensor and the other sensor (2) is an optical sensor. In addition, the arrangement contains means for processing the signals of the sensors. These means are arranged in a decentralised manner in the detectors and they contain a microcontroller (MCU) for conditioning the sensor signals and for signal processing for the purpose of obtaining danger signals. The danger signals are obtained in a neuronal network (NN). <IMAGE>
Patent DK-0646132-T3 (DK)
Inventor: REUTTER WERNER
IPC: A61P31/04
Filed: 1994-04-12
Granted: 2000-03-13
Abstract: The invention pertains to new amino sugars (neuraminic acid precursor analogues) and new glycoproteins, methods of preparing them, pharmaceutical agents containing them and their use in stimulating growth and differentiation of human and animal cells of the immune system and in preventing the adhesion of leucocytes, thrombocytes and tumor cells to vascular endothelium cells, also in stimulating the immune system, especially T-lymphocytes, warding off infections and treating weaknesses in the immune system, tumorous illnesses including metastatic processes, infectious diseases (viruses, bacteria, parasites, protozoa) and circulatory failures, especially vascular occlusions and septicemia, in humans and animals.
Patent DK-0722313-T3 (DK)
Inventor: KRAFFT MARIE-PIERRE
IPC: A61K8/70
Filed: 1994-10-01
Granted: 1999-11-15
Abstract: Compositions for topical application in gel form comprising a fluorocarbon or perfluorocarbon compound or mixtures thereof at a concentration of at least about 75% v/v, a minor quantity of a surface active agent and an aqueous phase. The compositions provide a storage-stable high concentration fluorocarbon gel that is prepared without the use of thickeners or additional stabilizing agents. The gels are useful in formulations for pharmaceutical, cosmetic purposes and for other products as well.
Patent DK-0667129-T3 (DK)
Inventor: YOUNG MICHAEL JOHN RADLEY
IPC: A61B17/56
Filed: 1992-08-24
Granted: 1999-03-08
Abstract: A tool for use in removing plastics material from a hole comprises a work surface adapted to contact the material. Piezo electric transducer means operatively connected through a work horn to the work surface cause it to vibrate ultrasonically and thereby to heat locally the plastics material. A cavity is adapted to received heated plastics material. The cavity is connected to a working zone adjacent the work surface. The work surface comprises a head flange and on a reverse side thereof a substantially annular cutting edge formed on one side of a conical face angled to the general direction of the tool.
Patent DK-0739417-T3 (DK)
Inventor: MOECKEL BETTINA
IPC: C12N15/09
Filed: 1995-01-09
Granted: 2004-01-05
Abstract: PCT No. PCT/DE95/00017 Sec. 371 Date Mar. 20, 1997 Sec. 102(e) Date Mar. 20, 1997 PCT Filed Jan. 9, 1995 PCT Pub. No. WO95/19442 PCT Pub. Date Jul. 20, 1995The invention relates to processes for the microbial production of L-isoleucine. To this end, in a gene in vitro of a threonine dehydratse, one or more bases in the gene region coding the enzyme's allosteric domains are exchanged in such a way that at least one amino acid in the amino acid sequence of the allosteric domains of the enzyme is replaced by another so that the enzyme is no longer inhibited by L-isoleucine feedback. Furthermore, concrete amino acid exchanges in the amino acid sequence of the enzyme are effected in a gene in vitro of a threonin dehydratase of Corynebacterium glutamicum by base exchange both outside and inside and outside the gene region coding the allosteric domains of the enzyme si that, after the transformation of such mutated threonine dehydratase genes into a threonine or L-isoleucine-producing host cell, the latter repeatedly forms L-isoleucine.
Patent DK-0740625-T3 (DK)
Inventor: LOHR ROBERT
IPC: B62D1/26
Filed: 1995-01-23
Granted: 1999-03-22
Abstract: PCT No. PCT/FR95/00066 Sec. 371 Date Jul. 25, 1996 Sec. 102(e) Date Jul. 25, 1996 PCT Filed Jan. 23, 1995 PCT Pub. No. WO95/20516 PCT Pub. Date Aug. 3, 1995A two-state directional control linkage (11) for controlling a steering axle, comprising a device for activating and deactivating the linkage (11) to lock the linkage in the operative position of the device and unlock it in the inoperative position thereof such that said device no longer transmits control movements. The linkage is particularly useful in public transport road vehicles.
Patent DK-0814787-T3 (DK)
Inventor: JONES CHRISTOPHER BUCHAN
IPC: A61K/
Filed: 1995-03-17
Granted: 2003-01-06
Abstract: Sterile pharmaceutical compsn. for parenteral admin. is an oil-in-water emulsion in which propofol (I) (2,6-diisopropylphenol), opt. dissolved in a water-immiscible solvent, is emulsified with water and stabilised by surfactant. It also includes enough EDTA or salt to prevent growth of microorganisms for at least 24 hr after accidental contamination. Also new are similar emulsions that do not contain (I) but may contain some other therapeutic or pharmaceutical agent (II), opt. dissolved in organic solvent.
Patent DK-0747389-T3 (DK)
Inventor: MATSUDA AKIRA
IPC: C07H19/06
Filed: 1995-12-13
Granted: 2004-01-26
Abstract: The invention relates to a 3'-substituted nucleoside derivative represented by the following general formula (1): <CHEM> wherein B means a nucleic acid base which may have a substituent, Z represents a lower alkynyl or lower alkenyl group which may be substituted by a group represented by the formula: <CHEM> in which R<a>, R<b> and R<c> are individually a lower alkyl group or a phenyl group, or an oxiranyl group which may have at least one lower alkyl group, R<1> and R<2> individually represent H or an ester-forming residue capable of easily leaving in a living body, and R<3> is H, a mono- or polyphosphoric acid residue, or an ester-forming residue capable of easily leaving in a living body, with the proviso that the sugar moiety is ribose, or a pharmaceutically acceptable salt thereof. The 3'-substituted nucleoside derivative according to the invention has an excellent antitumor activity and is hence useful for treatment for and prevention of cancers.
Patent DK-0739423-T3 (DK)
Inventor: WILDING PETER
IPC: C12Q1/68
Filed: 1995-11-13
Granted: 2002-05-06
Abstract: Disclosed are devices for amplifying a preselected polynucleotide in a sample by conducting a polynucleotide amplification reaction. The devices are provided with a substrate microfabricated to include a polynucleotide amplification reaction chamber, having at least one cross-sectional dimension of about 0.1 to 1000  mu m. The device also includes at least one port in fluid communication with the reaction chamber, for introducing a sample to the chamber, for venting the chamber when necessary, and, optionally, for removing products or waste material from the device. The reaction chamber may be provided with reagents required for amplification of a preselected polynucleotide. The device also may include means for thermally regulating the contents of the reaction chamber, to amplify a preselected polynucleotide. Preferably, the reaction chamber is fabricated with a high surface to volume ratio, to facilitate thermal regulation. The amplification reaction chamber also may be provided with a composition which diminishes inhibition of the amplification reaction by material comprising a wall of the reaction chamber, when such treatment is required.
Patent DK-0744505-T3 (DK)
Inventor: TIERLICH JOCHEN
IPC: E04D13/04
Filed: 1996-05-09
Granted: 2000-10-16
Abstract: The roof terrace comprises a floor element and at least four wall elements. The weather surfaces of these elements have an integral plastics weather shell (1). A room-side shell of individual supporting plates (2) of fibre-reinforced inorganic and/or organic material is provided at least in the area of the wall elements and is spaced from the weather shell by hollow plastics profiled sections (4). A damp course layer (3) is placed on the weather-side faces of these plates (2). The interspaces between the plastics profiled sections are fitted with heat barrier plates. At least one part of the hollow plastics profiles has a reinforcement inlay. The floor element can include a drain pipe (1.5) and/or heating installation channels.
Patent DK-0734701-T3 (DK)
Inventor: KUBEIN-MEESENBURG DIETMAR PROF
IPC: A61F2/30
Filed: 1992-12-08
Granted: 2001-02-05
Abstract: The toroidal-form joint surfaces (4, 5) have, in a longitudinal plane and a cross plane different circular-shaped intersection contours as function surfaces, whereby the curvature conditions of the function surfaces in each of the planes are either convex-convex, convex-concave, or concave-concave. The joint geometry of the function surfaces in each of the planes is determined by a joint chain with two joint axes which run through the rotation centres (M1, M2) of the function surfaces with specific radii.